Sharpe ratio is not yet available for TLGUX. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar mutual funds
The table compares Morgan Stanley Pathway Funds Large Cap Equity Fund's Sharpe Ratio with other mutual funds in the Large Cap Blend Equities category across multiple time periods, showing how TLGUX's risk-adjusted performance compares to similar funds.
Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 30, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| VPCCX | Vanguard PRIMECAP Core Fund | 3.26 | |||
| VPMAX | Vanguard PRIMECAP Fund Admiral Shares | 3.07 | |||
| POSKX | PrimeCap Odyssey Stock Fund | 2.82 | |||
| FTZIX | Fuller & Thaler Behavioral Unconstrained Equity Fund | 2.68 | |||
| GTLOX | Glenmede Quantitative U.S. Large Cap Core Equity Portfolio | 2.62 | |||
| RESGX | Glenmede Responsible ESG U.S. Equity Portfolio | 2.60 | |||
| ORDNX | North Square Preferred and Income Securities Fund | 2.51 | |||
| DHAMX | Centre American Select Equity Fund | 2.51 | |||
| MISEX | Midas Magic | 2.49 | |||
| STFGX | State Farm Growth Fund | 2.42 | |||
| TLGUX | Morgan Stanley Pathway Funds Large Cap Equity Fund | — |
Loading charts...
How does TLGUX fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio